Tag: TGEN
-
Unlocking the immune system’s potential to fight skin cancer
Karen Hastings, MD, PhD, is exploring how neoantigens can be used as a target for vaccines to help fight skin cancer. When Karen Hastings, MD, PhD, chose to make Arizona her […]
-
Shaping the Future: Highlights from the 2nd State of the PBC Event
On December 3, 2024, the Phoenix Bioscience Core (PBC) hosted its 2nd annual State of the PBC event, drawing over 180 attendees from notable institutions such as ASU, NAU, UA, […]
-
Introducing Investor Corner PBC: A New Hub for Investor-Company Connections
PHOENIX, AZ (January 8, 2025) – The Phoenix Bioscience Core (PBC) is proud to announce the launch of Investor Corner PBC — a dedicated space for investors to connect with […]
-
Artist + Researcher Applications are open!
The Artist + Researcher program (ARx) at Phoenix Bioscience Core (PBC) is the largest initiative of the PBC Arts Committee, offering scientists the opportunity to collaborate with local artists to […]
-
TGen Launches Center For Spatial Multi-Omics (COSMO): A Service Center Dedicated To Transforming Biomedical Research Through Spatial Biology
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of the Center for Spatial Multi-Omics (COSMO), a service center dedicated to transforming biomedical research through spatial biology. […]
-
TGen study reveals genetic drivers of common liver disease
Meta-analysis points to potential new therapeutic pathways PHOENIX, AZ — In the largest study of its kind, researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, […]
-
City of Hope appoints Aleksandar Sekulic to key cancer genomics role at TGen
City of Hope today announced the appointment of Aleksandar Sekulic, M.D., Ph.D., as a professor in the Integrated Cancer Genomics Division at Translational Genomics Research Institute (TGen).
-
City of Hope names Alan Bryce chief clinical officer at City of Hope Cancer Center Phoenix, professor of molecular medicine at TGen
City of Hope announced the appointment of Alan H. Bryce, M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen).
-
City of Hope, TGen awarded five-year, $4.5 million grant to advance liquid biopsy for pancreatic cancer
The City of Hope and the Translational Genomics Research Institute (TGen) announced they’d received $4.5 million from the National Cancer Institute
-
TGen, City of Hope researchers develop early detection method for pancreatic cancer
Researchers at the Translational Genomics Research Institute, which is part of the City of Hope, have developed an early detection method for pancreatic cancer.